Evidence map›Paper›PMID 31119612›Full record

ArticleInternational journal of hematology2019

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Hirokazu Murakami, Tetsuhiro Kasamatsu, Jun Murakami, Toru Kiguchi, Takeshi Kanematsu, Daisuke Ogawa, Hiroyuki Takamatsu, Hiroshi Handa, Shuji Ozaki, Hirokazu Miki and 6 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Hirokazu MurakamiDepartment of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan. hmura@gunma-u.ac.jp.
Tetsuhiro KasamatsuDepartment of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan.
Jun MurakamiDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Toru KiguchiDepartment of Hematology, Chugoku Central Hospital, Fukuyama, Japan.
Takeshi KanematsuDepartment of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.
Daisuke OgawaDepartment of Hematology, Nagasaki Prefectural Shimabara Hospital, Shimabara, Japan.
Hiroyuki TakamatsuDepartment of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
Hiroshi HandaDepartment of Hematology, Gunma University, Maebashi, Japan.
Shuji OzakiDepartment of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Hirokazu MikiDivision of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
Takeshi TakahashiDepartment of Hematology, Gifu Municipal Hospital, Gifu, Japan.
Takaaki TakeoDepartment of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan.
Tatsuya YamauchiDepartment of Hematology, Toki Municipal General Hospital, Toki, Japan.
Takanobu MorishitaDepartment of Hematology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan.
Hiroshi KosugiDepartment of Hematology, Ogaki Municipal Hospital, Ogaki, Japan.
Kazuyuki ShimizuDepartment of Hematology/Oncology, Higashi Nagoya National Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors would like to correct the errors in the publication of the original article. The correction details are given below.

Identifiers

PMID31119612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.